Compare AU

Compare DRUG vs. GXLD

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are DRUG and GXLD. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

GXLD

Popularity

Low

Low

Pearlers invested

65

5

Median incremental investment

$990.50

$993.50

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,935.78

$1,062.10

Average age group

26 - 35

26 - 35


Key Summary

DRUG

GXLD

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

GXLD.AX was created on 2024-04-29 by Global X. The fund's investment portfolio concentrates primarily on gold commodities. The Global X Gold Bullion ETF (GXLD.AX) seeks to provide a return that tracks the performance of the price of gold bullion in Australian dollars

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Global X Gold Bullion ETF (100 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

0.15 %


Key Summary

DRUG

GXLD

Issuer

BetaShares

Global X

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Solactive Gold Spot London Close Index - AUD - Benchmark TR Net

Asset class

ETF

ETF

Management fee

0.57 %

0.15 %

Price

$8.38

$40.85

Size

$182.401 million

$14.793 million

10Y return

N/A

N/A

Annual distribution/ dividend yield (5Y)

1.90 %

- %

Market

ASX

ASX

First listed date

08/08/2016

30/04/2024

Purchase fee

$6.50

$6.50


Community Stats

DRUG

GXLD

Popularity

Low

Low

Pearlers invested

65

5

Median incremental investment

$990.50

$993.50

Median investment frequency

Monthly

Fortnightly

Median total investment

$1,935.78

$1,062.10

Average age group

26 - 35

26 - 35


Pros and Cons

DRUG

GXLD

Pros

  • Higher exposure to US market

  • Higher price growth

  • Higher distribution yield

  • Lower management fee

Cons

  • Higher management fee

  • Lower exposure to US market

  • Lower price growth

  • Lower distribution yield

DRUG

GXLD

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home